Showing results (11-20 of 2,317) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|July 8, 2014
Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib?Christian Rolfo, Francesco Passiglia, Antonio Russo, et al.Expert Opinion on Therapeutic Targets|May 19, 2016
Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injurySami H Tuffaha, Prateush Singh, Joshua D Budihardjo, et al.Expert Opinion on Therapeutic Targets|May 20, 2016
Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discoverySugunadevi Sakkiah, Hui Wen Ng, Weida Tong, et al.Expert Opinion on Therapeutic Targets|February 16, 2016
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistanceLaura Garros-Regulez, Paula Aldaz, Olatz Arrizabalaga, et al.Expert Opinion on Therapeutic Targets|February 26, 2016
Therapeutic targeting of CD70 and CD27Harald WajantExpert Opinion on Therapeutic Targets|August 4, 2016
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cellsMarianna Colamaio, Nadia Tosti, Francesca Puca, et al.Expert Opinion on Therapeutic Targets|July 23, 2015
Keratinocyte growth factor receptor: a therapeutic target in solid cancerLiu Hong, Yu Han, Jinqiang Liu, et al.Expert Opinion on Therapeutic Targets|December 23, 2024
An update on the role of ferroptosis in ischemic stroke: from molecular pathways to NeuroprotectionA Gowtham, Chandan Chauhan, Vikrant Rahi, et al.Expert Opinion on Therapeutic Targets|December 9, 2024
miR-181a: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potentialGrace McIntyre, Zoe Jackson, Jose Colina, et al.Expert Opinion on Therapeutic Targets|November 10, 2024
Immunotherapies in breast cancer: harnessing the cancer immunity cycleVincent Lok, Sy Olson-McPeek, Grace Spiegelhoff, et al.Pageof 232